← Leaderboards
Yuliya Pylayeva-Gupta
Univ Of North Carolina Chapel Hill
$4,145,109
Attributed
$5,259,272
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,259,272 · 4
By mechanism
R37$3,030,945 · 1
R01$1,584,951 · 1
R21$392,037 · 1
T32$251,339 · 1
Top collaborators
- Paul A Dayton3 shared
- Henry Shelton Earp3 shared
- Channing J Der1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Kathleen M Caron$16,068,293
- Neil Alexis$2,976,096
- Sudhanshu Handa$7,325,766
- Ilona Jaspers$20,767,326
- Zibo Li$7,321,417
Others in their field
Other Emerging Leaders on “T-Lymphocyte”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Crystal Mackall · Children'S Hosp Of Philadelphia$16,367,876
- Wilton B Williams · Duke University$16,226,847
- Gary Fanger · Rise Therapeutics, Llc$15,372,982
- Aaron Esser-Kahn · University Of Chicago$13,378,548
Research focus
T-LymphocyteMalignant Neoplasm Of PancreasMediatingSignal TransductionImmuneMouse ModelImmunotherapyMalignant NeoplasmsOperative Surgical ProceduresResponseTumorTumor MicroenvironmentPancreatic Ductal AdenocarcinomaResistanceCellsEffector T CellDiagnosisTumor-Immune System InteractionsAnti-Pd-1Cell PhysiologyImmunoregulationAntigensCd8-Positive T-LymphocytesCessation Of Life
Grant awards (14)
Divergent Roles of MerTK,Tyro3, and Axl in Pancreatic Cancer and Metastasis$537,271
R01 · FY2025 · CA
Function of IL35+ B cells in pancreatic cancer$417,022
R37 · FY2025 · CA · contact PI
Cancer Cell Biology Training Program$251,339
T32 · FY2025 · CA
Divergent Roles of MerTK,Tyro3, and Axl in Pancreatic Cancer and Metastasis$510,409
R01 · FY2024 · CA
Function of IL35+ B cells in pancreatic cancer$396,171
R37 · FY2024 · CA · contact PI
Divergent Roles of MerTK,Tyro3, and Axl in Pancreatic Cancer and Metastasis$537,271
R01 · FY2023 · CA
Function of IL35+ B cells in pancreatic cancer$394,032
R37 · FY2023 · CA · contact PI
Function of IL35+ B cells in pancreatic cancer$443,047
R37 · FY2022 · CA · contact PI
Parametric optimization of ultrasound-mediated immuno-modulation for pancreatic cancer therapy$104,640
R21 · FY2022 · CA
Function of IL35+ B cells in pancreatic cancer$446,826
R37 · FY2021 · CA · contact PI
Parametric optimization of ultrasound-mediated immuno-modulation for pancreatic cancer therapy$108,171
R21 · FY2021 · CA
Function of IL35+ B cells in pancreatic cancer$471,387
R37 · FY2020 · CA · contact PI
Parametric optimization of ultrasound-mediated immuno-modulation for pancreatic cancer therapy$179,226
R21 · FY2020 · CA
Function of IL35+ B cells in pancreatic cancer$462,460
R37 · FY2019 · CA · contact PI